argenx SE
NASDAQ:ARGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
argenx SE
NASDAQ:ARGX
|
NL |
|
N
|
Nordex SE
DUS:NDX1
|
DE |
|
J
|
Jollibee Foods Corp
XPHS:JFC
|
PH |
|
Cipla Ltd
BSE:500087
|
IN |
|
A
|
Airbus SE
F:AIR
|
NL |
|
AGC Inc
OTC:ASGLY
|
JP |
|
A
|
Anglo American Platinum Ltd
XBER:RPHA
|
ZA |
|
R
|
Reading International Inc
NASDAQ:RDIB
|
US |
|
Ultrajaya Milk Industry Tbk PT
IDX:ULTJ
|
ID |
|
Evolution AB (publ)
OTC:EVVTY
|
SE |
|
Leone Film Group SpA
MIL:LFG
|
IT |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
Hummingbird Resources PLC
LSE:HUM
|
UK |
|
Laurent Perrier SA
PAR:LPE
|
FR |
|
Couchbase Inc
NASDAQ:BASE
|
US |
|
C
|
Campbell Soup Co
XBER:CSC
|
US |
|
SBC Exports Ltd
NSE:SBC
|
IN |
|
Gilead Sciences Inc
NASDAQ:GILD
|
US |
|
Wuxi Hyatech Co Ltd
SSE:688510
|
CN |
|
L
|
L'Oreal SA
OTC:LRLCF
|
FR |
|
Pinnacle Financial Partners Inc
NASDAQ:PNFP
|
US |
|
C
|
Colgate-Palmolive Co
DUS:CPA
|
US |
|
R
|
Region Re Ltd
ASX:RGN
|
AU |
|
D
|
Devon Energy Corp
DUS:DY6
|
US |
Bankruptcy Probability
argenx SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
argenx SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
177.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
30.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
argenx SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, argenx SE has total debt of 36.3m USD. This includes both short-term (0 USD) and long-term (36.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
